Chemical nature and pharmacokinetic features
Chemically, losartan is an imidazole derivative. When taken orally, the drug demonstrates fairly rapid absorption in the gastrointestinal tract. However, its bioavailability is relatively low, at only 30–35%. This means that only about a third of the administered dose reaches the systemic circulation unchanged.
A key pharmacokinetic feature of the drug is its intensive metabolism. Passing through the liver, the parent drug undergoes biotransformation, resulting in the synthesis of an active metabolite. This metabolite plays a crucial role in the therapeutic effect, as its pharmacological activity exceeds that of losartan itself by 10–40 times.
The difference between the parent drug and its derivative is also evident in the rate of elimination from the body. The half-life ($t_{1/2}$) for losartan itself is very short, ranging from 1.5 to 2 hours. At the same time, the active metabolite circulates in the blood significantly longer, with a half-life reaching 6–9 hours. It is precisely due to this prolonged presence of the active component in the blood that patients only need to take the drug once a day to maintain a stable effect.
Pharmacodynamics and dual antagonism
The mechanism of action is based on the blockade of AT_1 receptors, but this process is dual in nature due to the presence of two active molecules in the patient's blood:
- Losartan itself acts as a competitive antagonist. It competes with endogenous ligands for binding to the receptor.
- The active hepatic metabolite acts as a non-competitive antagonist of AT_1 receptors. It binds to the receptor in a way that provides a more potent and prolonged blockade.
Systemic pharmacological effects
Receptor blockade triggers a cascade of reactions that ultimately lead to the normalization of the patient's condition. The main effects can be divided into several categories:
- Hemodynamic effects. The drug effectively reduces blood vessel tone. This logically leads to a decrease in total peripheral resistance (TPR) and a sustained drop in blood pressure. In addition, by dilating the vascular bed, cardiac afterload is significantly reduced, facilitating myocardial workload.
- Water-electrolyte balance. Under the influence of the drug, aldosterone secretion decreases. The reduction in this hormone's level triggers natriuretic and diuretic effects — the body begins to excrete sodium ions along with excess fluid more actively.
- Specific feature. Unlike many other antihypertensive agents, losartan has a pronounced uricosuric effect. This means the drug purposely promotes the excretion of uric acid from the body.
Safety profile and adverse effects
Despite its high efficacy, therapy may be accompanied by adverse reactions. The side effects of losartan are completely analogous to the general reactions characteristic of the entire drug class.
Among the most frequent complaints are systemic dizziness and fatigue. Furthermore, both the physician and the patient must keep in mind the risk of allergic reactions, particularly angioedema.
Briefly: answers to topical questions
What are the main indications and contraindications for prescribing losartan in clinical practice?
Main evidence-based indications for losartan:
Indications / clinical situations:
- Hypertension — losartan belongs to angiotensin II receptor blockers (ARBs), which are among the main classes of antihypertensive drugs; ARBs can be used in initial therapy in combination with a calcium channel blocker or a diuretic.
- Chronic heart failure — losartan is an ARB representative in CHF; used as an alternative when ACE inhibitors are not tolerated, with dry cough being a frequent reason for switching. Also, ARIIs, including losartan, are indicated as an alternative to ARNI or ACE inhibitors if they are not tolerated.
- Stable ischemic heart disease (IHD) with comorbid conditions affecting prognosis — in case of ACE inhibitor intolerance, ARBs are prescribed for the same indications; losartan is listed among the preferred ARBs for IHD and CHF.
- IgA nephropathy — dosages for losartan are specified: average dose according to studies is 0.8 mg/kg/day, starting dose for ages 6–9 is 0.7 mg/kg once daily.
Contraindications:
- Explicit contraindications to prescribing losartan are not specified in the cited sources.
Side effects / limitations indicated in sources:
- For ARBs: hyperkalemia, elevated creatinine, teratogenicity; cough and angioedema are less common than with ACE inhibitors.
- For losartan: side effects are similar to the class-wide effects, including dizziness, fatigue, angioedema.
To remember the specifics of the drug, use the association: "LOSARTAN is a vine (loza) that roots in the liver and drops acidic leaves." "Roots in the liver" reminds you that it is precisely there where the active metabolite is formed, which is 10–40 times stronger than the drug itself. And "drops acidic leaves" is a reference to its unique uricosuric action (excretion of uric acid). Also remember the double game: the parent drug is a competitive player for receptors, while its metabolite is non-competitive.
Class and exam questions
What is the chemical nature of losartan?
Chemically, the drug is an imidazole derivative.
Why is losartan prescribed only once a day despite its short half-life?
Losartan itself is indeed eliminated quickly (half-life of 1.5–2 hours). However, an active metabolite is formed from it in the liver, which is 10–40 times stronger than the parent compound. The half-life of this metabolite is 6–9 hours, which ensures a sustained therapeutic effect throughout the day.
How does the drug lower blood pressure?
Blood pressure reduction is achieved by decreasing vascular tone and dropping total peripheral resistance (TPR). An additional contribution comes from reducing aldosterone secretion, which leads to the excretion of sodium and excess fluid.
What is the main specific difference between losartan and other drugs?
Its unique feature is its uricosuric action. The drug not only lowers blood pressure but also actively promotes the excretion of uric acid from the body.
What else to study on this topic
- Biotransformation of imidazole derivatives: how the liver synthesizes active metabolites
- Hemodynamics in detail: the relationship between TPR reduction and cardiac afterload
- Receptor interaction mechanisms: competitive and non-competitive antagonism of AT1 receptors
- The role of aldosterone in water-electrolyte balance regulation and mechanisms of natriuresis
- Pathophysiology of angioedema as a class-wide adverse effect
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Losartan" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Cardiovascular Drugs"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.